NYSE:TMO Thermo Fisher Scientific (TMO) Stock Price, News & Analysis $704.41 +11.39 (+1.64%) Closing price 03:59 PM EasternExtended Trading$707.72 +3.32 (+0.47%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Thermo Fisher Scientific Stock (NYSE:TMO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TMO alerts:Sign Up Key Stats Today's Range$691.03▼$710.8450-Day Range$600.32▼$704.4152-Week Range$435.27▼$710.84Volume1.65 million shsAverage Volume2.27 million shsMarket Capitalization$260.45 billionP/E Ratio37.15Dividend Yield0.27%Price Target$681.00Consensus RatingModerate Buy Company Overview Thermo Fisher Scientific Inc. is a global supplier of laboratory products, analytical instruments, reagents, consumables, software and services used in scientific research, healthcare, pharmaceuticals, biotechnology and industrial applications. The company serves customers ranging from academic institutions and government agencies to hospitals, clinical laboratories and pharmaceutical manufacturers. Its offerings include instruments and systems for genetic analysis, mass spectrometry, chromatography, electron microscopy and materials science, as well as molecular biology reagents, cell culture products, laboratory plastics and research chemicals. Through its laboratory services and contract development and manufacturing operations, Thermo Fisher also supports pharmaceutical and biotechnology companies with drug development, clinical research and manufacturing services. The company operates internationally through brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Its products and services are distributed and provided across North America, Europe, Asia-Pacific and other global markets. Thermo Fisher Scientific was formed in 2006 through the merger of Thermo Electron and Fisher Scientific. Marc N. Casper serves as the company’s president and chief executive officer.AI Generated. May Contain Errors. Read More Thermo Fisher Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks80th Percentile Overall ScoreTMO MarketRank™: 3.993024157085 of 5 starsThermo Fisher Scientific scored higher than 80% of companies evaluated by MarketBeat, and ranked 84th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.4 / 5Analyst RatingModerate Buy Consensus RatingThermo Fisher Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.84, and is based on 2 strong buy ratings, 18 buy ratings, 4 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Thermo Fisher Scientific is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageThermo Fisher Scientific has been the subject of 18 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Thermo Fisher Scientific's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.03% Earnings GrowthEarnings for Thermo Fisher Scientific are expected to grow by 10.03% in the coming year, from $25.23 to $27.76 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Thermo Fisher Scientific is 37.15, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.05.Price to Earnings Ratio vs. SectorThe P/E ratio of Thermo Fisher Scientific is 37.15, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 36.90.Price to Earnings Growth RatioThermo Fisher Scientific has a PEG Ratio of 2.75. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioThermo Fisher Scientific has a P/B Ratio of 4.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.33% of the float of Thermo Fisher Scientific has been sold short.Short Interest Ratio / Days to CoverThermo Fisher Scientific has a short interest ratio ("days to cover") of 2.15, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Thermo Fisher Scientific has recently decreased by 9.63%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldThermo Fisher Scientific has a dividend yield of 0.28%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthThermo Fisher Scientific has been increasing its dividend for 8 years.Dividend CoverageThe dividend payout ratio of Thermo Fisher Scientific is 9.92%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 6.77% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.Read more about Thermo Fisher Scientific's dividend. News and Social Media4.3 / 5News Sentiment0.82 News SentimentThermo Fisher Scientific has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 32 news articles for Thermo Fisher Scientific this week, compared to 9 articles on an average week.Search Interest40 people have searched for TMO on MarketBeat in the last 30 days. This is an increase of 82% compared to the previous 30 days.MarketBeat Follows15 people have added Thermo Fisher Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 650% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Thermo Fisher Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $43,896,820.00 in company stock.Percentage Held by Insiders0.33% of the stock of Thermo Fisher Scientific is held by insiders.Percentage Held by Institutions89.23% of the stock of Thermo Fisher Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Thermo Fisher Scientific's insider trading history. Receive TMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TMO Stock News HeadlinesCustom Recombinant Protein Production Services Market Projected to Reach $10.21 Billion by 2030 | Thermo Fisher, Merck, GenScript, and Sino Biological DominateOctober 28 at 1:14 PM | finance.yahoo.comMicroarray Scanners - Global Strategic Business Report 2026: Capitalize on $1.6 Billion Industry Revenue by 2032 | Thermo Fisher Scientific, Agilent Technologies, Illumina, and Bio-Rad Laboratories DominateOctober 28 at 1:14 PM | finance.yahoo.comHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.October 28 at 1:00 AM | Banyan Hill Publishing (Ad)Cell and Gene Therapy Contract Research Organization Market Report 2026 | Capitalize on 12.3% CAGR as Thermo Fisher, IQVIA, Labcorp, ICON, and WuXi AppTec Scale Integrated TrialsOctober 26 at 4:07 PM | finance.yahoo.com3 healthcare stocks we keep off our radarOctober 26 at 4:07 PM | finance.yahoo.comThermo Fisher Scientific (NYSE:TMO) Cut to Hold at DZ BankOctober 26 at 1:54 AM | americanbankingnews.comThermo Fisher Scientific (NYSE:TMO) Stock Price Expected to Rise, Stifel Nicolaus Analyst SaysOctober 24, 2026 | americanbankingnews.comQuantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built (TMO)Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial.October 15, 2026 | marketbeat.comSee More Headlines TMO Stock Analysis - Frequently Asked Questions How have TMO shares performed this year? Thermo Fisher Scientific's stock was trading at $579.42 at the beginning of the year. Since then, TMO shares have increased by 21.6% and is now trading at $704.4080. How were Thermo Fisher Scientific's earnings last quarter? Thermo Fisher Scientific Inc. (NYSE:TMO) announced its quarterly earnings results on Wednesday, October, 21st. The medical research company reported $6.68 EPS for the quarter, topping analysts' consensus estimates of $6.40 by $0.28. The company's revenue for the quarter was up 9.1% compared to the same quarter last year. Read the conference call transcript. Is Thermo Fisher Scientific doing a stock buyback? Thermo Fisher Scientific's Board of Directors initiated a stock buyback plan on Thursday, November 6th 2025, which permits the company to buy back $5 billion in shares, according to EventVestor. This means that the company could reacquire up to 2.4% of its shares through open market purchases. Shares buyback plans are often an indication that the company's leadership believes its stock is undervalued. Does Thermo Fisher Scientific have any subsidiaries? The following companies are subsidiaries of Thermo Fisher Scientific: Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and more. Who are Thermo Fisher Scientific's major shareholders? Top institutional shareholders of Thermo Fisher Scientific include Canoe Financial LP (0.08%), James Hambro & Partners LLP (0.06%), Asset Management One Co. Ltd. (0.06%) and Douglas Lane & Associates LLC (0.06%). Insiders that own company stock include Marc N Casper, Michel Lagarde, Stephen Williamson, Gianluca Pettiti, Michael D Shafer, Lisa P Britt, Frederick M Lowery, Michael A Boxer, Joseph R Holmes and Debora L Spar. View institutional ownership trends. How do I buy shares of Thermo Fisher Scientific? Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Thermo Fisher Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include NVIDIA (NVDA), Visa (V), Salesforce (CRM), Advanced Micro Devices (AMD), Tesla (TSLA), Mastercard (MA) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 10/15 Dividend9/15/2026Ex-Dividend for 10/15 Dividend9/15/2026Dividend Payable10/15/2026Last Earnings10/21/2026Today10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 TMO's financial health is in the Green zone, according to TradeSmith. TMO has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:TMO CIK97745 Webwww.thermofisher.com Phone(781) 622-1000Fax781-622-1207Employees125,000Year Founded1956Price Target and Rating Average Price Target for Thermo Fisher Scientific$681.00 High Price Target$810.00 Low Price Target$520.00 Potential Upside/Downside-3.3%Consensus RatingModerate Buy Rating Score (0-4)2.84 Research Coverage25 Analysts Profitability EPS (Trailing Twelve Months)$18.96 Trailing P/E Ratio37.15 Forward P/E Ratio27.92 P/E Growth2.75Net Income$6.70 billion Net Margins14.94% Pretax Margin16.68% Return on Equity17.33% Return on Assets8.18% Debt Debt-to-Equity Ratio0.71 Current Ratio1.81 Quick Ratio1.41 Sales & Book Value Annual Sales$47.35 billion Price / Sales5.50 Cash Flow$31.79 per share Price / Cash Flow22.16 Book Value$142.17 per share Price / Book4.95Miscellaneous Outstanding Shares369,747,000Free Float368,527,000Market Cap$260.45 billion OptionableOptionable Beta0.87 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:TMO) was last updated on 10/28/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredElon gets it. Do you?Moderna shares surged almost 200% in a single day after a successful phase 3 trial for its cancer drug, while ...Porter & Company | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
